Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (1-10 of 333) with videos related to

Pageof 34
Sort By:
Seminars in Hematology|July 1, 1988
The role of interferons in the treatment of hematologic malignanciesJ U Gutterman
Cancer|August 15, 1992
Biologic therapy of human cancerJ U Gutterman
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Cytokine therapeutics: lessons from interferon alphaJ U Gutterman
Nature Biotechnology|July 1, 1997
Clinical investigators: the driving force behind drug discoveryJ U Gutterman
Progress in Clinical and Biological Research|January 1, 1989
Clinical and biological activity of the interferons in hematologic malignanciesJ U Gutterman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Recreating an environment for clinical discoveryJ U Gutterman
Biochemical and Biophysical Research Communications|April 16, 1996
The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domainD Choubey, J U Gutterman
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1979
Effect of glucan on natural killer (NK) cells: further comparison between NK cell and bone marrow effector cell activitiesE Lotzová, J U Gutterman
Oncogene|July 17, 1997
Inhibition of E2F-4/DP-1-stimulated transcription by p202D Choubey, J U Gutterman
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 13, 1999
Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1)J U Gutterman, D Choubey
Pageof 34

Showing results (1-10 of 333) with videos related to

Sort By:
Pageof 34
Seminars in Hematology|July 1, 1988
The role of interferons in the treatment of hematologic malignanciesJ U Gutterman
Cancer|August 15, 1992
Biologic therapy of human cancerJ U Gutterman
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Cytokine therapeutics: lessons from interferon alphaJ U Gutterman
Nature Biotechnology|July 1, 1997
Clinical investigators: the driving force behind drug discoveryJ U Gutterman
Progress in Clinical and Biological Research|January 1, 1989
Clinical and biological activity of the interferons in hematologic malignanciesJ U Gutterman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Recreating an environment for clinical discoveryJ U Gutterman
Biochemical and Biophysical Research Communications|April 16, 1996
The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domainD Choubey, J U Gutterman
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1979
Effect of glucan on natural killer (NK) cells: further comparison between NK cell and bone marrow effector cell activitiesE Lotzová, J U Gutterman
Oncogene|July 17, 1997
Inhibition of E2F-4/DP-1-stimulated transcription by p202D Choubey, J U Gutterman
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 13, 1999
Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1)J U Gutterman, D Choubey
Pageof 34